| It is a derivative of Pyrazolone having analgesic and antipyretic activity.
| Composition : | 1mg/2ml, 15mg/30ml | | Indications : | Pain, Fever. | | Contraindications : | Hypersensitivity, hepatic porphyria,Collapse states, infants less than 3 month of age or 5kg body wt. | | Safety Profile : | Disorders of haematopoiesis. | | Adverse Effects : | Hypersensitivity, bronchial tract, gastric symptoms. | | Drug Interactions | Cyclosporine level increased. | | Dosage : | Adults : Oral ; 0.5-1.5gm in 2-3divided doses. Parenteral : 2ml IM. 2-3 times daily.Children : Oral 30-60 mg/kg/day
Parenteral (All four times/day by slow IV) : 3 month to 1 year : 0.1ml, below 5 years : 0.2ml, 5-7 years : 0.4ml, 8-11 years : 0.5ml, 12-14 years : 0.8ml | | Purity : | Not less than 99%. |
|
 |
© Health Biotech Limited. All Rights Reserved (Terms of Use)
